Mode
Text Size
Log in / Sign up
Phase 2 N=7 Treatment

Thymus Transplantation Dose in DiGeorge #932

DiGeorge Anomaly · DiGeorge Syndrome · Complete DiGeorge Anomaly · Complete DiGeorge Syndrome

Enrolled (actual)
7
Serious AEs
85.7%
Results posted
Feb 2020
Primary outcome: Primary: Survival at 1 Year Post-CTTI — 83 % of participants who survive to 1 year

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Cultured Thymus Tissue Implantation (CTTI) (Biological); Cultured Thymus Tissue Implantation with Parathyroid Transplantation (Other)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Sumitomo Pharma Switzerland GmbH
Primary completion
Nov 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Survival at 1 Year Post-CTTI
83
SECONDARY
Survival at 2 Years Post-CTTI
83
SECONDARY
Immune Reconstitution Efficacy - CD3 T Cells
635
SECONDARY
Immune Reconstitution Efficacy - CD4 T Cells
499
SECONDARY
Immune Reconstitution Efficacy - CD8 T Cells
116
SECONDARY
Immune Reconstitution Efficacy - Naive CD4 T Cells
279
SECONDARY
Immune Reconstitution Efficacy - Naive CD8 T Cells
214
SECONDARY
Immune Reconstitution Efficacy - Response to Mitogens
135016
SECONDARY
Thymus Allograft Biopsy
1; 0; 1

Summary

One purpose of this study is to determine whether the amount of cultured thymus tissue implanted into DiGeorge anomaly infants has any effect on the immune outcome. Another purpose of this study is to determine whether parental parathyroid transplantation (in addition to cultured thymus tissue implantation (CTTI) can help both the immune and the calcium problems in DiGeorge infants with hypocalcemia. [Funding Source - FDA Office of Orphan Products Development (OOPD)]

Eligibility Criteria

Thymus Transplant Inclusion Criteria:

  • A parent or guardian of the DGS subject signed the consent form.
  • Medical screening was completed.
  • For a diagnosis of DGS, the subject had to have one of the following:
  • Congenital heart disease;
  • Hypocalcemia requiring replacement;
  • 22q11.2 hemizygosity or 10p13 hemizygosity;
  • CHARGE association or CHD7 mutation;
  • A subject with abnormal ears whose mother had diabetes (type I, type II, or gestational).
  • To meet the criteria of typical complete DiGeorge Anomaly (cDGA), the subject had to have either:
  • Circulating CD3+ T cell count by flow cytometry 18 years old
  • Answers all questionnaire items and meets safety screening criteria
  • Normal serum calcium
  • Normal PTH function
  • HLA typing consistent with parentage
  • Parent chosen for donation will share HLA-DR allele in thymus donor; if not applicable, then either parent will be selected (if meet all other criteria).
  • Must not be on anticoagulation or can come off for donation/transplantation

Parental Parathyroid Donor Exclusion:

  • Donor is only living involved parent or caretaker of the recipient
  • Hypoparathyroidism - low parathyroid hormone (PTH) in presence of low serum calcium and high serum phosphate
  • Hyperparathyroidism (or history of) - elevated PTH in presence of high serum calcium and low serum phosphate
  • History of cancer
  • Evidence of any of following: HIV-1, HIV-2, HTLV-1, HTLV-2, syphilis, hepatitis B, hepatitis C, West Nile virus, or Trypanosoma Cruzi (Chagas disease)
  • Elevated AST, ALT, alkaline phosphatase > 3 times upper limit of normal
  • History including receipt of a xenograft or risk factors for SARS, Mad Cow - Disease or smallpox. Note: if parent has Mad Cow Disease risk factors (but not active disease), parent(s) may give permission for transplantation.
  • CMV positive urine
  • Positive CMV IgM antibodies
  • Positive IgM anti-EBV VCA
  • On blood thinners and cannot stop for the parathyroid donation
  • Elevated PT or PTT (> ULN)
  • Platelets < 100,000
  • Positive Toxoplasma IgM
  • The donor will receive a history and physical; may be excluded based on PI's medical judgment
  • Hemoglobin < 9 g/dl
  • Infectious lesion on head or neck
  • Goiter on ultrasound
  • Abnormal fiberoptic laryngoscopy of vocal cords
  • Pregnancy
  • Positive HSV IgG is not an exclusion; however, post transplantation prophylaxis is needed
  • Positive VZV IgG is not an exclusion; however, post transplantation prophylaxis is needed
  • Medical concern of otolaryngologist
  • Concern by medical psychologist or social worker. Parents are interviewed together and separately regarding following areas: medical history; health habits; substance use; relationships and support; education/work history; mental status/psychological history; readiness for donation.
  • Questionnaire (safety screening) responses can lead to exclusion.

Biological Mother of DiGeorge Subject Inclusion Criteria:

  • Competent to provide consent
  • Willing to provide blood for testing (No other inclusion/exclusion for mother)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00576836). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search